Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.52+0.43 (+1.48%)
Close on Nov 17, 2026Market cap $1.11BP/E –Yield –
Harrow operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Harrow's operating cash flow for the twelve months ending Jun 30, 2026 was $6.25M, up 54.9% year over year. For fiscal 2025 it was $43.86M. The highest annual figure on record is $43.86M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.86M | – |
| FY2024 | Dec 31, 2024 | -$22.20M | -678.2% |
| FY2023 | Dec 31, 2023 | $3.84M | +125.2% |
| FY2022 | Dec 31, 2022 | $1.71M | -66.5% |
| FY2021 | Dec 31, 2021 | $5.08M | – |
| FY2020 | Dec 31, 2020 | -$1.10M | -215.8% |
| FY2019 | Dec 31, 2019 | $950.00K | +38.3% |
| FY2018 | Dec 31, 2018 | $687.00K | – |
| FY2017 | Dec 31, 2017 | -$8.80M | – |
| FY2016 | Dec 31, 2016 | -$11.22M | – |
| FY2015 | Dec 31, 2015 | -$11.14M | – |
| FY2014 | Dec 31, 2014 | -$7.06M | – |
| FY2013 | Dec 31, 2013 | -$4.44M | – |
| FY2012 | Dec 31, 2012 | -$1.90M | – |
| FY2011 | Dec 31, 2011 | -$291.16K | – |
| FY2010 | Dec 31, 2010 | -$2.30M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.76M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.99M | -145.7% |
| Q4 FY2025 | Dec 31, 2025 | $8.41M | – |
| Q3 FY2025 | Sep 30, 2025 | $16.59M | +462.1% |
| Q2 FY2025 | Jun 30, 2025 | -$803.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $19.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.78M | -304.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.75M | -160.1% |
| Q1 FY2024 | Mar 31, 2024 | -$4.63M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.70M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.21M | – |
| Q2 FY2023 | Jun 30, 2023 | $4.57M | -6.0% |
| Q1 FY2023 | Mar 31, 2023 | -$8.21M | -949.4% |
| Q4 FY2022 | Dec 31, 2022 | -$3.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$410.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $4.86M | -10.7% |
| Q1 FY2022 | Mar 31, 2022 | $967.00K | -69.9% |
| Q4 FY2021 | Dec 31, 2021 | -$1.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.08M | -177.8% |
| Q2 FY2021 | Jun 30, 2021 | $5.44M | – |
| Q1 FY2021 | Mar 31, 2021 | $3.21M | – |
| Q4 FY2020 | Dec 31, 2020 | -$566.00K | -134.3% |
| Q3 FY2020 | Sep 30, 2020 | $2.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.65M | -414.1% |
| Q1 FY2020 | Mar 31, 2020 | -$550.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $1.65M | – |
| Q3 FY2019 | Sep 30, 2019 | -$70.00K | -121.7% |
| Q2 FY2019 | Jun 30, 2019 | $844.00K | -38.2% |
| Q1 FY2019 | Mar 31, 2019 | -$1.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$36.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $323.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $1.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$965.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$294.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.22M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.31M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.98M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.24M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.91M | – |
See a number that looks wrong?